PA8596801A1 - Derivados de acido acetico sustituido con cicloalquilmetoxi, procedimientos para su preparacion y su uso como farmacos - Google Patents

Derivados de acido acetico sustituido con cicloalquilmetoxi, procedimientos para su preparacion y su uso como farmacos

Info

Publication number: PA8596801A1
Authority: PA; Panama
Prior art keywords: derivatives; procedures; preparation; acetic acid; cycloalkylmetoxi
Prior art date: 2003-02-27

Application number

PA20048596801A

Other languages

English (en)

Spanish (es)

Inventor

Heiner Glombik

Dirk Gretzke

Eugen Falk

Jochen Goerlitzer

Stefanie Keil

Hans-Ludwig Schaefer

Christian Stapper

Wolgang Wendler

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-27

Filing date

2004-02-27

Publication date

2004-09-16

2004-02-27 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2004-09-16 Publication of PA8596801A1 publication Critical patent/PA8596801A1/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Diabetes (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)

PA20048596801A 2003-02-27 2004-02-27 Derivados de acido acetico sustituido con cicloalquilmetoxi, procedimientos para su preparacion y su uso como farmacos PA8596801A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10308355A DE10308355A1 (de)	2003-02-27	2003-02-27	Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel

Publications (1)

Publication Number	Publication Date
PA8596801A1 true PA8596801A1 (es)	2004-09-16

Family

ID=32920629

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PA20048596801A PA8596801A1 (es)	2003-02-27	2004-02-27	Derivados de acido acetico sustituido con cicloalquilmetoxi, procedimientos para su preparacion y su uso como farmacos

Country Status (34)

Country	Link
US (5)	US7259177B2 (pl)
EP (3)	EP1599455B1 (pl)
JP (3)	JP2006519194A (pl)
KR (3)	KR20050105492A (pl)
CN (3)	CN100439345C (pl)
AR (3)	AR043427A1 (pl)
AT (3)	ATE430738T1 (pl)
AU (3)	AU2004215672B2 (pl)
BR (3)	BRPI0407814A (pl)
CA (3)	CA2516620A1 (pl)
CL (2)	CL2004000391A1 (pl)
CO (2)	CO5690578A2 (pl)
DE (4)	DE10308355A1 (pl)
DK (3)	DK1599455T3 (pl)
EC (2)	ECSP055986A (pl)
ES (3)	ES2326418T3 (pl)
HR (3)	HRP20050742A2 (pl)
IL (2)	IL170316A (pl)
MA (3)	MA27736A1 (pl)
MX (3)	MXPA05008988A (pl)
NO (3)	NO20054408L (pl)
OA (2)	OA13035A (pl)
PA (1)	PA8596801A1 (pl)
PE (3)	PE20040959A1 (pl)
PL (3)	PL377735A1 (pl)
PT (3)	PT1599452E (pl)
RS (1)	RS20050594A (pl)
RU (3)	RU2005129995A (pl)
SA (1)	SA04250153A (pl)
TN (2)	TNSN05206A1 (pl)
TW (3)	TW200510352A (pl)
UY (2)	UY28210A1 (pl)
WO (3)	WO2004076427A1 (pl)
ZA (2)	ZA200505768B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7576131B2 (en)	1999-06-04	2009-08-18	Metabolex, Inc.	Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US6262118B1 (en) *	1999-06-04	2001-07-17	Metabolex, Inc.	Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US7399777B2 (en) *	2001-08-31	2008-07-15	Sanofi-Aventis Deutschland Gmbh	Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals
DE10308353A1 (de) *	2003-02-27	2004-12-02	Aventis Pharma Deutschland Gmbh	Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102004038403B4 (de) *	2004-08-07	2006-08-31	Sanofi-Aventis Deutschland Gmbh	Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 3-Hydroxycyclohexancarbonsäure-Derivaten
DE102004039533B4 (de)	2004-08-14	2006-09-28	Sanofi-Aventis Deutschland Gmbh	Essigsäurederivate mit Cyclohexylmethoxy-Substituenten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE102004039509B4 (de)	2004-08-14	2006-09-21	Sanofi-Aventis Deutschland Gmbh	Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102004039532B4 (de)	2004-08-14	2006-09-21	Sanofi-Aventis Deutschland Gmbh	Cyclohexyl-methyloxy substituierte Essigsäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE102004060227B3 (de) *	2004-12-15	2006-07-20	Sanofi-Aventis Deutschland Gmbh	Verfahren zur Herstellung von Oxazolen durch Kondensation von aromatischen Aldehyden mit α-Ketoximen zu N-Oxiden und nachfolgende Reaktion mit aktivierten Säurederivaten
GT200600218A (es) *	2005-06-10	2007-03-28		Formulación y proceso de compresión directa
AU2006299091A1 (en)	2005-09-29	2007-04-12	Sanofi-Aventis	Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
BRPI0621960A2 (pt)	2006-08-10	2011-12-27	Wood One Co Ltd	composiÇço hipoglicÊmica contendo derivado da casca de acÁcia
JP5340287B2 (ja)	2007-08-16	2013-11-13	ソルヴェイ（ソシエテアノニム）	４−フルオロ置換３−オキソ−アルカン酸のエステル類の調製方法
US8399685B2 (en)	2008-02-29	2013-03-19	Nissan Chemical Industries, Ltd.	Process for producing thiophene compound and intermediate thereof
US7615661B2 (en) *	2008-03-12	2009-11-10	International Flavors & Fragrances Inc.	Thioester compounds and their use in fragrance or flavor applications
KR102640007B1 (ko)	2017-12-13	2024-02-27	캐논 가부시끼가이샤	프로세스 카트리지
CN109810071B (zh) *	2019-03-28	2023-04-21	中国科学院成都生物研究所	一种miRNA生物合成抑制剂

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2663336B1 (fr)	1990-06-18	1992-09-04	Adir	Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2663464B1 (fr)	1990-06-19	1992-09-11	Commissariat Energie Atomique	Circuit integre en technologie silicium sur isolant comportant un transistor a effet de champ et son procede de fabrication.
ZA941003B (en)	1993-02-15	1995-08-14	Wellcome Found	Hypolipidaemic compounds
IL108634A0 (en)	1993-02-15	1994-05-30	Wellcome Found	Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them
JP3144624B2 (ja)	1995-06-02	2001-03-12	杏林製薬株式会社	Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
CA2241567A1 (en)	1996-01-17	1997-07-24	Novo Nordisk A/S	Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
CA2264243C (en)	1996-08-30	2004-10-05	Novo Nordisk A/S	Glp-1 derivatives
TW492957B (en)	1996-11-07	2002-07-01	Novartis Ag	N-substituted 2-cyanopyrrolidnes
CN1190434C (zh)	1996-12-31	2005-02-23	雷迪实验室有限公司	新的杂环化合物、其制备方法和含有它们的药物组合物及其在治疗糖尿病和相关疾病中的应用
DE19726167B4 (de)	1997-06-20	2008-01-24	Sanofi-Aventis Deutschland Gmbh	Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
JP2001510195A (ja)	1997-07-16	2001-07-31	ノボノルディスクアクティーゼルスカブ	縮合化１，２，４−チアジアジン誘導体、その調製及び使用
CO4970713A1 (es)	1997-09-19	2000-11-07	Sanofi Synthelabo	Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
DE69941777D1 (de) *	1998-03-10	2010-01-21	Ono Pharmaceutical Co	Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
DE19823831A1 (de)	1998-05-28	1999-12-02	Probiodrug Ges Fuer Arzneim	Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
SE9801992D0 (sv)	1998-06-04	1998-06-04	Astra Ab	New 3-aryl-2-hydroxypropionic acid derivative I
MA26634A1 (fr)	1998-06-04	2004-12-20	Astra Ab	Nouveaux derives de l'acide 3-aryl propionique et analogues
US6221897B1 (en)	1998-06-10	2001-04-24	Aventis Pharma Deutschland Gmbh	Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19828114A1 (de)	1998-06-24	2000-01-27	Probiodrug Ges Fuer Arzneim	Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
DE19828113A1 (de)	1998-06-24	2000-01-05	Probiodrug Ges Fuer Arzneim	Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
WO2000012491A1 (fr) *	1998-08-27	2000-03-09	Ono Pharmaceutical Co., Ltd.	Derives d'acide carboxylique et medicaments dont ils sont le principe actif
DE19845405C2 (de)	1998-10-02	2000-07-13	Aventis Pharma Gmbh	Arylsubstituierte Propanolaminderivate und deren Verwendung
GB9900416D0 (en)	1999-01-08	1999-02-24	Alizyme Therapeutics Ltd	Inhibitors
DE19916108C1 (de)	1999-04-09	2001-01-11	Aventis Pharma Gmbh	Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
US6908926B1 (en)	1999-04-16	2005-06-21	Novo Nordisk A/S	Substituted imidazoles, their preparation and use
JP2002542245A (ja)	1999-04-16	2002-12-10	ノボノルディスクアクティーゼルスカブ	置換イミダゾール、それらの製造および使用
MXPA01010880A (es)	1999-04-28	2002-05-06	Aventis Pharma Gmbh	Derivados de acido diarilico como ligandos de receptor ppar.
EE200100558A (et) *	1999-04-28	2002-12-16	Aventis Pharma Deutschland Gmbh	Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
WO2000066585A1 (en)	1999-04-30	2000-11-09	Neurogen Corporation	9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS
GB9911863D0 (en)	1999-05-21	1999-07-21	Knoll Ag	Therapeutic agents
CA2376919C (en)	1999-06-18	2008-11-04	Merck & Co., Inc.	Arylthiazolidinedione and aryloxazolidinedione derivatives
WO2001004146A2 (en)	1999-07-09	2001-01-18	Cohesion Technologies, Inc.	Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof
PT1204654E (pt)	1999-07-29	2003-11-28	Lilly Co Eli	Benzofurilpiperazinas agonistas do receptor 5-ht2c da serotonina
CA2383781A1 (en)	1999-09-01	2001-03-08	Aventis Pharma Deutschland Gmbh	Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
TWI302149B (en)	1999-09-22	2008-10-21	Bristol Myers Squibb Co	Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
PL357118A1 (pl)	1999-12-03	2004-07-12	Astrazeneca Ab	Postać krystaliczna kwasu (S)-2-etoksy-3-[4-(2-{4-metanosulfonyloksyfenylo} etoksy) fenylo] propanowego
SE9904413D0 (sv)	1999-12-03	1999-12-03	Astra Ab	Comminuted form
EP2266665B1 (en)	2000-03-31	2016-05-11	Royalty Pharma Collection Trust	Method for the improvement of islet signaling in diabetes mellitus and for its prevention
KR20030007548A (ko)	2000-04-25	2003-01-23	교린 세이야꾸 가부시키 가이샤	티아졸리딘디온 유도체의 신규한 안정한 결정 및 이의제조방법
PT1277736E (pt)	2000-04-28	2007-10-12	Asahi Kasei Pharma Corp	Novos compostos bicíclicos
BR0110638A (pt)	2000-05-11	2003-03-25	Bristol Myers Squibb Co	Análogos de tetraidroisoquinolina úteis como secretagogos de hormÈnio do crescimento
WO2001091752A1 (en)	2000-05-30	2001-12-06	Merck & Co., Inc.	Melanocortin receptor agonists
SK17252002A3 (sk)	2000-06-09	2003-05-02	Aventis Pharma Deutschland Gmbh	Deriváty acylfenylmočoviny, spôsoby ich výroby a použitie ako liečivo
DE10038709A1 (de)	2000-08-09	2002-02-28	Aventis Pharma Gmbh	Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen
EP1182251A1 (en) *	2000-08-11	2002-02-27	Yissum Research Development Company of the Hebrew University of Jerusalem	Methods for identifying compounds that inhibit ubiquitin-mediated proteolysis of IkB
EA200300286A1 (ru) *	2000-08-23	2003-08-28	Эли Лилли Энд Компани	Агонисты активируемых пероксисомальным пролифератором рецепторов
DE60129712T2 (de)	2000-08-23	2008-07-03	Eli Lilly And Co., Indianapolis	Oxazolylaryloxyessigsäure derivate und ihre verwendung als ppar agonisten
TWI243162B (en)	2000-11-10	2005-11-11	Taisho Pharmaceutical Co Ltd	Cyanopyrrolidine derivatives
JPWO2002046146A1 (ja)	2000-12-05	2004-04-08	杏林製薬株式会社	置換カルボン酸誘導体
GB0031103D0 (en) *	2000-12-20	2001-01-31	Glaxo Group Ltd	Chemical compounds
CA2431983C (en)	2000-12-21	2010-06-08	Aventis Pharma Deutschland Gmbh	Novel 1,2-diphenylazetidinones, processes for their preparation, medicaments comprising these compounds and their use for treating impaired lipid metabolism
EP1726586A1 (en) *	2000-12-25	2006-11-29	Ono Pharmaceutical Co., Ltd.	Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
JP2004529097A (ja)	2001-02-15	2004-09-24	ファイザー・プロダクツ・インク	Ｐｐａｒアゴニスト
PE20021091A1 (es)	2001-05-25	2003-02-04	Aventis Pharma Gmbh	Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
MXPA03010903A (es) *	2001-06-07	2004-02-17	Lilly Co Eli	Moduladores de receptores activados por el proliferador de peroxisomas.
DE10154689A1 (de)	2001-11-09	2003-05-22	Probiodrug Ag	Substituierte Aminoketonverbindungen
WO2003005025A1 (en)	2001-07-03	2003-01-16	Biovitrum Ab	Methods for identifying compounds modulating the activity of ppar-gamma
FR2827859B1 (fr)	2001-07-30	2005-09-23	Lipha	Derives 4-(arylthio) - ou 4-(heteroarylthio) -butyrique dans la preparation de medicaments destines au traitement du diabete
JP4436129B2 (ja)	2001-08-31	2010-03-24	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	ジアリールシクロアルキル誘導体、その製造法及びｐｐａｒ−活性剤としてのその使用
WO2003066581A1 (en)	2002-02-05	2003-08-14	Eli Lilly And Company	Urea linker derivatives for use as ppar modulators
IL164249A0 (en)	2002-04-11	2005-12-18	Aventis Pharma Gmbh	Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use
DE10215908B4 (de)	2002-04-11	2005-08-18	Aventis Pharma Deutschland Gmbh	Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel
DE10225635C1 (de)	2002-06-07	2003-12-24	Aventis Pharma Gmbh	N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
EP1656368A4 (en)	2002-07-09	2009-08-26	Bristol Myers Squibb Co	SUBSTITUTED HETEROCYCLIC DERIVATIVES USEFUL AS ANTIDIABETIC AGENTS AND ANTIABESITY AND THEIR MANUFACTURING PROCESS
US7148246B2 (en) *	2003-02-27	2006-12-12	Sanofi-Aventis Deutschland Gmbh	Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals

2003
- 2003-02-27 DE DE10308355A patent/DE10308355A1/de not_active Withdrawn
2004
- 2004-02-19 CA CA002516620A patent/CA2516620A1/en not_active Abandoned
- 2004-02-19 AT AT04712494T patent/ATE430738T1/de not_active IP Right Cessation
- 2004-02-19 WO PCT/EP2004/001579 patent/WO2004076427A1/de active IP Right Grant
- 2004-02-19 WO PCT/EP2004/001578 patent/WO2004076426A1/de active Application Filing
- 2004-02-19 RS YUP-2005/0594A patent/RS20050594A/sr unknown
- 2004-02-19 MX MXPA05008988A patent/MXPA05008988A/es active IP Right Grant
- 2004-02-19 JP JP2006501886A patent/JP2006519194A/ja active Pending
- 2004-02-19 DK DK04712503T patent/DK1599455T3/da active
- 2004-02-19 DE DE502004009690T patent/DE502004009690D1/de not_active Expired - Lifetime
- 2004-02-19 RU RU2005129995/04A patent/RU2005129995A/ru not_active Application Discontinuation
- 2004-02-19 AU AU2004215672A patent/AU2004215672B2/en not_active Ceased
- 2004-02-19 DE DE502004004139T patent/DE502004004139D1/de not_active Expired - Lifetime
- 2004-02-19 PL PL377735A patent/PL377735A1/pl not_active Application Discontinuation
- 2004-02-19 PL PL378437A patent/PL378437A1/pl not_active Application Discontinuation
- 2004-02-19 KR KR1020057015851A patent/KR20050105492A/ko not_active Application Discontinuation
- 2004-02-19 AU AU2004215677A patent/AU2004215677B2/en not_active Ceased
- 2004-02-19 RU RU2005130002/04A patent/RU2005130002A/ru not_active Application Discontinuation
- 2004-02-19 PL PL378130A patent/PL378130A1/pl not_active Application Discontinuation
- 2004-02-19 OA OA1200500248A patent/OA13035A/en unknown
- 2004-02-19 CN CNB2004800054379A patent/CN100439345C/zh not_active Expired - Fee Related
- 2004-02-19 DK DK04712494T patent/DK1599453T3/da active
- 2004-02-19 PT PT04712490T patent/PT1599452E/pt unknown
- 2004-02-19 JP JP2006501885A patent/JP2006519193A/ja active Pending
- 2004-02-19 EP EP04712503A patent/EP1599455B1/de not_active Expired - Lifetime
- 2004-02-19 CA CA002517386A patent/CA2517386A1/en not_active Abandoned
- 2004-02-19 BR BRPI0407814-4A patent/BRPI0407814A/pt not_active IP Right Cessation
- 2004-02-19 PT PT04712494T patent/PT1599453E/pt unknown
- 2004-02-19 AT AT04712490T patent/ATE365159T1/de not_active IP Right Cessation
- 2004-02-19 CA CA002517381A patent/CA2517381A1/en not_active Abandoned
- 2004-02-19 ES ES04712494T patent/ES2326418T3/es not_active Expired - Lifetime
- 2004-02-19 PT PT04712503T patent/PT1599455E/pt unknown
- 2004-02-19 DK DK04712490T patent/DK1599452T3/da active
- 2004-02-19 KR KR1020057015995A patent/KR20050106461A/ko not_active Application Discontinuation
- 2004-02-19 BR BRPI0407907-8A patent/BRPI0407907A/pt not_active IP Right Cessation
- 2004-02-19 RU RU2005129992/04A patent/RU2005129992A/ru not_active Application Discontinuation
- 2004-02-19 DE DE502004009453T patent/DE502004009453D1/de not_active Expired - Lifetime
- 2004-02-19 KR KR1020057016023A patent/KR20050106462A/ko not_active Application Discontinuation
- 2004-02-19 MX MXPA05008995A patent/MXPA05008995A/es active IP Right Grant
- 2004-02-19 BR BRPI0407758-0A patent/BRPI0407758A/pt not_active IP Right Cessation
- 2004-02-19 ES ES04712503T patent/ES2329366T3/es not_active Expired - Lifetime
- 2004-02-19 MX MXPA05008951A patent/MXPA05008951A/es active IP Right Grant
- 2004-02-19 AT AT04712503T patent/ATE435217T1/de not_active IP Right Cessation
- 2004-02-19 EP EP04712490A patent/EP1599452B1/de not_active Expired - Lifetime
- 2004-02-19 AU AU2004215673A patent/AU2004215673B2/en not_active Ceased
- 2004-02-19 EP EP04712494A patent/EP1599453B1/de not_active Expired - Lifetime
- 2004-02-19 JP JP2006501892A patent/JP2006519199A/ja active Pending
- 2004-02-19 OA OA1200500247A patent/OA13034A/en unknown
- 2004-02-19 CN CNB2004800054985A patent/CN100398526C/zh not_active Expired - Fee Related
- 2004-02-19 WO PCT/EP2004/001586 patent/WO2004076428A1/de active Application Filing
- 2004-02-19 ES ES04712490T patent/ES2287700T3/es not_active Expired - Lifetime
- 2004-02-19 CN CNB2004800054769A patent/CN100439347C/zh not_active Expired - Fee Related
- 2004-02-25 TW TW093104705A patent/TW200510352A/zh unknown
- 2004-02-25 TW TW093104704A patent/TW200500349A/zh unknown
- 2004-02-25 TW TW093104697A patent/TW200508210A/zh unknown
- 2004-02-27 UY UY28210A patent/UY28210A1/es unknown
- 2004-02-27 US US10/788,996 patent/US7259177B2/en active Active
- 2004-02-27 CL CL200400391A patent/CL2004000391A1/es unknown
- 2004-02-27 UY UY28209A patent/UY28209A1/es unknown
- 2004-02-27 AR ARP040100629A patent/AR043427A1/es not_active Application Discontinuation
- 2004-02-27 CL CL200400392A patent/CL2004000392A1/es unknown
- 2004-02-27 AR ARP040100635A patent/AR043432A1/es not_active Application Discontinuation
- 2004-02-27 PE PE2004000206A patent/PE20040959A1/es not_active Application Discontinuation
- 2004-02-27 AR ARP040100636A patent/AR043433A1/es not_active Application Discontinuation
- 2004-02-27 US US10/788,997 patent/US7365084B2/en not_active Expired - Fee Related
- 2004-02-27 PA PA20048596801A patent/PA8596801A1/es unknown
- 2004-02-27 PE PE2004000203A patent/PE20050292A1/es not_active Application Discontinuation
- 2004-02-27 PE PE2004000205A patent/PE20050293A1/es not_active Application Discontinuation
- 2004-02-27 US US10/789,017 patent/US7335671B2/en not_active Expired - Lifetime
- 2004-06-09 SA SA04250153A patent/SA04250153A/ar unknown
2005
- 2005-07-19 ZA ZA200505768A patent/ZA200505768B/en unknown
- 2005-07-19 ZA ZA200505765A patent/ZA200505765B/en unknown
- 2005-08-16 IL IL170316A patent/IL170316A/en not_active IP Right Cessation
- 2005-08-16 IL IL170314A patent/IL170314A/en not_active IP Right Cessation
- 2005-08-26 HR HR20050742A patent/HRP20050742A2/xx not_active Application Discontinuation
- 2005-08-26 TN TNP2005000206A patent/TNSN05206A1/en unknown
- 2005-08-26 MA MA28459A patent/MA27736A1/fr unknown
- 2005-08-26 CO CO05085499A patent/CO5690578A2/es not_active Application Discontinuation
- 2005-08-26 TN TNP2005000204A patent/TNSN05204A1/en unknown
- 2005-08-26 EC EC2005005986A patent/ECSP055986A/es unknown
- 2005-08-26 CO CO05085508A patent/CO5690580A2/es not_active Application Discontinuation
- 2005-08-26 HR HR20050744A patent/HRP20050744A2/xx not_active Application Discontinuation
- 2005-08-26 HR HR20050743A patent/HRP20050743A2/xx not_active Application Discontinuation
- 2005-08-26 MA MA28465A patent/MA27742A1/fr unknown
- 2005-08-26 MA MA28460A patent/MA27737A1/fr unknown
- 2005-08-26 EC EC2005005985A patent/ECSP055985A/es unknown
- 2005-09-22 NO NO20054408A patent/NO20054408L/no unknown
- 2005-09-22 NO NO20054396A patent/NO20054396L/no unknown
- 2005-09-22 NO NO20054398A patent/NO20054398L/no unknown
2007
- 2007-08-16 US US11/839,950 patent/US20080015238A1/en not_active Abandoned
2008
- 2008-01-14 US US12/013,806 patent/US7872034B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2004076427A1 (de)	2004-09-10
PL377735A1 (pl)	2006-02-20
US7365084B2 (en)	2008-04-29
US20050101637A1 (en)	2005-05-12
PE20040959A1 (es)	2005-01-17
CO5690580A2 (es)	2006-10-31
ATE430738T1 (de)	2009-05-15
RU2005129995A (ru)	2006-01-27
JP2006519199A (ja)	2006-08-24
PT1599453E (pt)	2009-07-14
CN1753879A (zh)	2006-03-29
RU2005129992A (ru)	2006-02-10
MA27736A1 (fr)	2006-02-01
JP2006519194A (ja)	2006-08-24
PE20050292A1 (es)	2005-05-24
MA27742A1 (fr)	2006-02-01
MXPA05008988A (es)	2005-10-18
NO20054398L (no)	2005-11-02
DK1599452T3 (da)	2007-10-01
KR20050106461A (ko)	2005-11-09
EP1599453B1 (de)	2009-05-06
ATE365159T1 (de)	2007-07-15
TW200500349A (en)	2005-01-01
AU2004215673B2 (en)	2009-10-01
AR043433A1 (es)	2005-07-27
PL378437A1 (pl)	2006-04-03
SA04250153A (ar)	2005-12-03
MXPA05008995A (es)	2005-10-18
TW200510352A (en)	2005-03-16
AU2004215673A1 (en)	2004-09-10
CN1756748A (zh)	2006-04-05
ECSP055986A (es)	2006-01-16
UY28209A1 (es)	2004-09-30
CA2517381A1 (en)	2004-09-10
NO20054408L (no)	2005-11-23
AU2004215677A1 (en)	2004-09-10
MXPA05008951A (es)	2005-11-04
WO2004076428A1 (de)	2004-09-10
OA13035A (en)	2006-11-10
AU2004215677B2 (en)	2010-01-07
RU2005130002A (ru)	2006-01-27
AU2004215672B2 (en)	2010-01-07
TNSN05206A1 (en)	2007-06-11
ES2326418T3 (es)	2009-10-09
WO2004076426A1 (de)	2004-09-10
NO20054396D0 (no)	2005-09-22
CA2517386A1 (en)	2004-09-10
BRPI0407814A (pt)	2006-02-14
EP1599453A1 (de)	2005-11-30
AU2004215672A1 (en)	2004-09-10
US20040209920A1 (en)	2004-10-21
ATE435217T1 (de)	2009-07-15
PE20050293A1 (es)	2005-05-24
EP1599452B1 (de)	2007-06-20
EP1599452A1 (de)	2005-11-30
DE502004009690D1 (de)	2009-08-13
CA2516620A1 (en)	2004-09-10
US7335671B2 (en)	2008-02-26
NO20054408D0 (no)	2005-09-22
MA27737A1 (fr)	2006-02-01
BRPI0407758A (pt)	2006-02-14
CN100439347C (zh)	2008-12-03
HRP20050742A2 (en)	2006-09-30
HRP20050744A2 (en)	2006-09-30
TW200508210A (en)	2005-03-01
PT1599455E (pt)	2009-09-29
RS20050594A (en)	2007-12-31
US20050215596A1 (en)	2005-09-29
OA13034A (en)	2006-11-10
NO20054396L (no)	2005-11-11
AR043432A1 (es)	2005-07-27
EP1599455A1 (de)	2005-11-30
ZA200505768B (en)	2005-11-23
EP1599455B1 (de)	2009-07-01
CL2004000391A1 (es)	2005-01-07
CO5690578A2 (es)	2006-10-31
US7259177B2 (en)	2007-08-21
ES2329366T3 (es)	2009-11-25
CN100398526C (zh)	2008-07-02
NO20054398D0 (no)	2005-09-22
US20080015238A1 (en)	2008-01-17
KR20050106462A (ko)	2005-11-09
DK1599453T3 (da)	2009-08-24
JP2006519193A (ja)	2006-08-24
DE502004004139D1 (de)	2007-08-02
PT1599452E (pt)	2007-09-12
US7872034B2 (en)	2011-01-18
ZA200505765B (en)	2006-05-31
TNSN05204A1 (en)	2007-06-11
AR043427A1 (es)	2005-07-27
DE10308355A1 (de)	2004-12-23
HRP20050743A2 (en)	2006-08-31
IL170316A (en)	2010-11-30
CL2004000392A1 (es)	2005-04-22
US20080167354A1 (en)	2008-07-10
BRPI0407907A (pt)	2006-02-14
CN1753881A (zh)	2006-03-29
CN100439345C (zh)	2008-12-03
ECSP055985A (es)	2006-01-16
KR20050105492A (ko)	2005-11-04
IL170314A (en)	2010-11-30
DK1599455T3 (da)	2009-11-09
DE502004009453D1 (de)	2009-06-18
ES2287700T3 (es)	2007-12-16
UY28210A1 (es)	2004-09-30
PL378130A1 (pl)	2006-03-06

Publication	Publication Date	Title
PA8596801A1 (es)	2004-09-16	Derivados de acido acetico sustituido con cicloalquilmetoxi, procedimientos para su preparacion y su uso como farmacos
DOP2006000205A (es)	2007-03-31	Derivados de fenil-1,2,4-oxadiazolona con grupo fenilo, procedimientos para su preparacion y su uso como productos farmaceuticos.
SV2009003293A (es)	2009-10-27	Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona, procedimiento para su preparacion y su uso como agentes farmaceuticos
PA8622401A1 (es)	2005-08-10	Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico,procesos para su preparacion y su uso como medicamentos
CO6300957A2 (es)	2011-07-21	Derivados de imidazo -[1,2,b]-piridazina para el tratamiento de enfermedad mediada por cinasa de tirosina c-met
UY31872A (es)	2010-01-29	Sulfonamidas n-heterocíclicas aneladas con grupo de cabeza de oxadiazolona, procesos para su preparación y su uso como sustancias farmacéuticas
UY30337A1 (es)	2008-01-02	Acidos carboxilicos sustituidos con 4,5-difenilpirimidinilo, procedimientos para su preparacion y su uso como productos farmacéuticos.
UY30339A1 (es)	2008-01-02	Acidos carboxilicos sustituidos con 4,5-difenilpirimidinilamino, procedimientos para su preparacion y su uso como productos farmacéuticos
UY31873A (es)	2010-01-29	Pirrolidin sulfonamidas aneladas con grupo de cabeza de oxadiazolona, procesos para su preparación y su uso como sustancias farmacéuticas
ECSP066892A (es)	2006-11-24	Derivados de oxadiazolona como agonistas de ppar delta
HN2008001666A (es)	2011-01-17	Derivados acidos de cicloalquilamino
UY31310A1 (es)	2009-04-30	Ácidos 6-fenilnicotínicos sustituidos y su uso
ECSP088322A (es)	2008-04-28	Derivados de fenil-1,2,4-oxadiazolona, procesos para su preparación y su uso como compuestos farmacéuticos
HN2011001019A (es)	2013-07-01	Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk) produccion y uso de los mismos como productos medicinales
UY32829A (es)	2011-03-31	Derivados de 3-heteroaril-metil-imidazo-[1,2-b]-pirididazin - 6 -ilo
UY29846A1 (es)	2007-05-31	N-(1,3,4)-tiadiazol-2-il-bencensulfonamidas, procesos para su preparación y su uso como productos farmacéuticos
UY29065A1 (es)	2006-02-24	Derivados del ácido alcanoico arilcicloalquil-sustituidos, procedimientos para su preparación y su uso como productos farmacéuticos.
UY31874A (es)	2010-01-29	Sulfonamidas con grupo de cabeza de heterociclo y oxadiazolona, procesos para su preparación y su uso como sustancias farmacéuticas
UY29847A1 (es)	2007-05-31	N-(1,3,4)-tiadiazol-2-il-bencensulfonamidas cíclicas, procesos para su preparación y su uso como productos farmacéuticos.
PA8596701A1 (es)	2004-09-16	Derivados de aminoacidos sustituidos con cicloalquilo, procedimiento para su preparacion y su uso como medicamentos
PA8641601A1 (es)	2006-03-24	Derivados del acido acetico con sustituyentes ciclohexilmetoxi, procedimiento para su preparacion y su uso como medicamentos
PA8596601A1 (es)	2004-09-16	Derivados cicloalquilo que tienen grupos acido carboxilico bioisostericos, procesos para su preparacion y su uso como composiciones farmaceuticas
UY29063A1 (es)	2006-02-24	Derivados del ácido acético con sustituyentes ciclohexilmetoxi, procedimiento para su preparación y su uso como medicamentos
DOP2005000153A (es)	2006-02-15	Derivados del acido con sustituyentes ciclohexilmetoxi, procedimiento para preparacion y su uso como medicamentos.
GT200600435A (es)	2007-03-21	Derivados de fenil-1,2,4-oxadiazolona con grupo fenilo, procedimientos para su preparación y su uso como productos farmacéuticos.